ClinicalTrials.govpublic full text
Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma
lymphoma, relapse b-cell cd20+ non-hodgkin's lymphoma, high-dose beam chemotherapy, y zevalin, in zevalin, rituxan, rituximab, bcnu, 1,3-bis(2-chloroethyl)-1-nitrosourea bis-chloronitrosourea, carmustine, bicnu, vp-16
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 851167
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.